UNIQURE NV
UniQure stock crashes over 50% today after FDA says Huntington’s therapy data isn’t enough - here's what investors need to knowQURE stock price today: UniQure's stock crashed Monday after the FDA declared data for its Huntington's disease gene therapy, AMT-130, insu...
Uniqure stock soars over 247% today after breakthrough Huntington’s disease drug resultsQure stock: UniQure's stock soared after AMT-130 gene therapy demonstrated a statistically significant slowing of Huntington's disease prog...
- Load More